Search News Releases

After two years during which Match Day ceremonies were held virtually due to the pandemic, the David Geffen School of Medicine at UCLA held the event in person on March 18 — and it was bigger and better than ever. 

In a new report, researchers say the challenges of treating long COVID are amplified by a critical issue: we do not know what constitutes long COVID or how to formally diagnose it, an issue that is further exacerbated by limited research data of varying quality and consistency.

UCLA Health, in partnership with BioscienceLA and UCLA Biodesign, has launched a new accelerator at the intersection of health equity and technology. Aimed at supporting long-term community health resilience and improvements in the aftermath of the COVID-19 pandemic, the UCLA Health TechQuity Accelerator seeks to bridge clinical excellence and innovation for diverse patient populations.

Researchers in a multi-institution study led by UCLA Health have identified several overlooked issues affecting women with Parkinson’s Disease (PD) and call for more research, customized treatments, education and support to empower women living with this disease and to address their unmet medical needs.

E. Dale Abel, MD, PhD, a distinguished endocrinologist with a lengthy record as a researcher and clinician and as a mentor to young scientists, has been appointed chair of the Department of Medicine at the David Geffen School of Medicine at UCLA and executive medical director of the UCLA Health System’s Department of Medicine.

The COVID-19 pandemic, geopolitical reckoning and new technologies have ushered in an era of seismic change in science and medicine. To help future leaders in health and healthcare navigate these transformations, the David Geffen School of Medicine at UCLA has designed DGSOM Heals, a new curriculum capable of adapting to shifting needs and empowering students with the skills in greatest demand by patients, employers and communities.

Three faculty members of the David Geffen School of Medicine at UCLA have been elected to the National Academy of Medicine, among the highest honors in the fields of medicine and health.

A new $13.3 million contract from the National Institutes of Health’s Rapid Acceleration of Diagnostics initiative will enable the David Geffen School of Medicine at UCLA to expand its capacity to process COVID-19 tests.